Foundation for innovation
in Cardiometabolism and Nutrition

IHU-ICAN

Communication

TRaining

clinical TEams

Cardiometabolism

INnovative care Pathways

Reference Centers

Research Teams

research

research focus Area

Our Support

clinical Investigation

scientific Plateforms

Parterships

Why Support ICAN?

How to support ICAN?

projects to Support

Research

  • General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

    General practitioners: Help with the early screening of patients at risk for metabolic fatty liver disease (GRIPonMASH project)

    ,
    Read More
  • Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Cardiovascular-kidney-metabolic (CKM): Toward a more integrated approach to cardiometabolic diseases

    Read More
  • ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ANNITIA Data Challenge: Using AI to Better Predict the Progression of Non-Alcoholic Fatty Liver Disease

    ,
    Read More
  • The women driving cardiometabolic research forward at the IHU ICAN

    The women driving cardiometabolic research forward at the IHU ICAN

    Read More
  • Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Discovery of a new biomarker for non-invasive diagnosis of MASH: thrombospondin-2 

    Read More
  • What impact do endocrine disruptors have on metabolic liver disease? Support from the Crédit Mutuel Alliance Fédérale Foundation

    What impact do endocrine disruptors have on metabolic liver disease? Support from the Crédit Mutuel Alliance Fédérale Foundation

    ,
    Read More
  • Clarivate ranking: 2 IHU ICAN researchers among the most cited in the world!

    Clarivate ranking: 2 IHU ICAN researchers among the most cited in the world!

    ,
    Read More
  • Supporting research into cardiometabolism: a commitment to the health of tomorrow

    Supporting research into cardiometabolism: a commitment to the health of tomorrow

    ,
    Read More
  • How can AI be used to stratify the risk of rare hereditary diseases?

    How can AI be used to stratify the risk of rare hereditary diseases?

    Read More
  • Physical activity: an important treatment in cardiac rehabilitation

    Physical activity: an important treatment in cardiac rehabilitation

    ,
    Read More

Stay in touch

Get all the latest news from the ICAN Foundation

This field is for validation purposes and should be left unchanged.

OUr founders

ISO 9001 Certified

OUr Institutionnal Supporters

Our network